Dupont Capital Management’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-19,808
Closed -$115K 1498
2022
Q3
$115K Buy
+19,808
New +$114K 0.01% 990
2021
Q3
Sell
-17,581
Closed -$615K 1798
2021
Q2
$615K Buy
+17,581
New +$511K 0.01% 872
2020
Q4
Sell
-96,079
Closed -$948K 1383
2020
Q3
$948K Sell
96,079
-20,228
-17% -$116K 0.02% 535
2020
Q2
$401K Buy
116,307
+17,090
+17% +$58.2K 0.01% 867
2020
Q1
$304K Sell
99,217
-146,999
-60% -$602K 0.01% 858
2019
Q4
$1.27M Buy
246,216
+76,360
+45% +$388K 0.03% 495
2019
Q3
$876K Sell
169,856
-40,307
-19% -$225K 0.02% 575
2019
Q2
$1.27M Buy
210,163
+125,760
+149% +$882K 0.03% 477
2019
Q1
$610K Buy
+84,403
New +$610K 0.01% 700

Other funds holding PACB